21/04/2017 12:08:00

Net Asset Value(s)

Related content
11:38 - 
Net Asset Value(s)
22 Jun - 
Net Asset Value(s)
22 Jun - 
Net Asset Value(s)

Invesco Asia Trust Plc - Net Asset Value(s)

PR Newswire

Invesco Asia Trust plc

As at close of business on 20-April-2017

NAV per Ordinary share (unaudited) with Debt at Par & Fair Value

EXCLUDING undistributed current year revenue 281.36p

INCLUDING current year revenue 285.99p

The fair value of debt is not materially different from the carrying value.

LEI: 549300YM9USHRKIET173

---

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

11:38 E:IAT
22 Jun E:IAT
22 Jun E:IAT
21 Jun E:IAT
20 Jun E:IAT
19 Jun E:IAT
16 Jun E:IAT
15 Jun E:IAT
14 Jun E:IAT
13 Jun E:IAT

Alliance Trust PLC : Transaction in Own Shares

14/06/2017 07:00:13
14 June 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 13 June 2017 the Company purchased for cancellation 209,000 ordinary shares of 2.5p each at a price of 708.0748p per share.  Therefore, the total number of voting rights in the Company is now 354,575,762.    The above figure (354,575,762) may be used by shareholder..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

13/06/2017 15:20:46
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Quarterly Update for the Quarter to 30 April 2017

13/06/2017 12:50:10
13 June 2017 ICG Enterprise Trust Plc Quarterly Update For the quarter to 30 April 2017 Highlights Share price Total Return1 of 5.7% for the quarter and 39.9% for the 12 months to 30 April 2017 Net asset value per share Total Return1 of 0.6% for the quarter and 19.9% for the 12 months The Portfolio1 is valued at £54..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Novartis combination targeted therapy Tafinlar® + Mekinist® receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC)
2
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA
3
Results of Operations for the Year Ended December 31, 2016 - American Overseas Group Limited Announces Net Loss Of $7.5 Million and Operating Loss of $14.6 Million For The Year Ended December 31, 2016
4
NXT Energy Solutions Announces Results of Annual General Meeting
5
Barrick and NOVAGOLD to Advance Ongoing Donlin Gold Project Optimization With Approved $8-Million Drill Program

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 June 2017 20:07:53
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170623.1 - EUROWEB1 - 2017-06-23 21:07:53 - 2017-06-23 20:07:53 - 1000 - Website: OKAY